Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20103634

Cancer Res. 2010 Feb 1 70 3 875-82

Download in:

View as

General Info

PMID
20103634